These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19653056)

  • 1. Efficacy of bosentan in the treatment of a patient with mixed connective tissue disease complicated by pulmonary arterial hypertension.
    Naclerio C; D'Angelo S; Baldi S; Tagliamonte G; Scarpato S
    Clin Rheumatol; 2010 Jun; 29(6):687-90. PubMed ID: 19653056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Two-years therapy with bosentan of pulmonary arterial hypertension related to connective tissue diseases].
    Marotta H; Montisci R; Tiso F; Pontarollo S; Rizzo M; Tona F; Iliceto S; Cozzi F
    Reumatismo; 2007; 59(4):299-303. PubMed ID: 18157286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consecutive use of sildenafil and bosentan for the treatment of pulmonary arterial hypertension associated with collagen vascular disease: sildenafil as reliever and bosentan as controller.
    Kamata Y; Iwamoto M; Minota S
    Lupus; 2007; 16(11):901-3. PubMed ID: 17971364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bosentan therapy of pulmonary arterial hypertension in connective tissue diseases.
    Cozzi F; Montisci R; Marotta H; Bobbo F; Durigon N; Ruscazio M; Sfriso P; Iliceto S; Todesco S
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():49-53. PubMed ID: 16919011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open-label, multicentre pilot study of bosentan in pulmonary arterial hypertension related to congenital heart disease.
    Ibrahim R; Granton JT; Mehta S
    Can Respir J; 2006; 13(8):415-20. PubMed ID: 17149459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of bosentan on the skin lesions: an observational study from a single center in Japan.
    Funauchi M; Kishimoto K; Shimazu H; Nagare Y; Hino S; Yano T; Kinoshita K
    Rheumatol Int; 2009 May; 29(7):769-75. PubMed ID: 19037604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bosentan improved syncope in a hemodialysis patient with pulmonary hypertension and mild aortic stenosis.
    Yamanaka A; Tasaki H; Suzuki Y; Tanaka S; Yamashita K; Tamura M; Abe H; Otsuji Y
    Int Heart J; 2006 Nov; 47(6):911-7. PubMed ID: 17268125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pulmonary arterial hypertension in connective tissue disease].
    Cottin V
    Rev Mal Respir; 2006 Sep; 23(4 Suppl):13S61-72. PubMed ID: 17057632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions.
    Denton CP; Humbert M; Rubin L; Black CM
    Ann Rheum Dis; 2006 Oct; 65(10):1336-40. PubMed ID: 16793845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Successful treatment for pulmonary hypertension with angiotensin 1 converting enzyme inhibitor in a patient with mixed connective tissue disease].
    Maekawa K; Fujimoto T; Uemura S; Kanauchi M; Dohi K
    Nihon Rinsho Meneki Gakkai Kaishi; 1997 Feb; 20(1):79-85. PubMed ID: 9105169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin receptor antagonism: role in the treatment of pulmonary arterial hypertension related to scleroderma.
    Kabunga P; Coghlan G
    Drugs; 2008; 68(12):1635-45. PubMed ID: 18681488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weaning of epoprostenol in a small infant receiving concomitant bosentan for severe pulmonary arterial hypertension secondary to bronchopulmonary dysplasia.
    Rugolotto S; Errico G; Beghini R; Ilic S; Richelli C; Padovani EM
    Minerva Pediatr; 2006 Oct; 58(5):491-4. PubMed ID: 17008861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of pulmonary arterial hypertension in a patient with systemic sclerosis.
    Distler JH; Hoeper MM; Distler O
    Nat Clin Pract Rheumatol; 2008 Mar; 4(3):160-4. PubMed ID: 18212761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of bosentan on matrix metalloproteinase-9 levels in patients with systemic sclerosis-induced pulmonary hypertension.
    Giannelli G; Iannone F; Marinosci F; Lapadula G; Antonaci S
    Curr Med Res Opin; 2005 Mar; 21(3):327-32. PubMed ID: 15811199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bosentan therapy for pulmonary arterial hypertension.
    Cohen H; Chahine C; Hui A; Mukherji R
    Am J Health Syst Pharm; 2004 Jun; 61(11):1107-19. PubMed ID: 15237563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of echocardiographic variables of right ventricular function with exercise capacity after bosentan treatment in patients with pulmonary arterial hypertension: Results from a multicenter, prospective, cohort study.
    Kim H; Bae Lee J; Park JH; Yoo BS; Son JW; Yang DH; Lee BR
    J Clin Ultrasound; 2017 Jan; 45(1):28-34. PubMed ID: 27619758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results from the EARLY study of bosentan in WHO functional class II pulmonary arterial hypertension patients.
    Simonneau G; Galiè N; Jansa P; Meyer GM; Al-Hiti H; Kusic-Pajic A; Lemarié JC; Hoeper MM; Rubin LJ
    Int J Cardiol; 2014 Mar; 172(2):332-9. PubMed ID: 24525158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bosentan therapy for pulmonary arterial hypertension.
    Rubin LJ; Badesch DB; Barst RJ; Galie N; Black CM; Keogh A; Pulido T; Frost A; Roux S; Leconte I; Landzberg M; Simonneau G
    N Engl J Med; 2002 Mar; 346(12):896-903. PubMed ID: 11907289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treprostinil-based therapy in the treatment of moderate-to-severe pulmonary arterial hypertension: long-term efficacy and combination with bosentan.
    Benza RL; Rayburn BK; Tallaj JA; Pamboukian SV; Bourge RC
    Chest; 2008 Jul; 134(1):139-45. PubMed ID: 18403673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist?
    van Loon RL; Hoendermis ES; Duffels MG; Vonk-Noordegraaf A; Mulder BJ; Hillege HL; Berger RM
    Am Heart J; 2007 Oct; 154(4):776-82. PubMed ID: 17893008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.